Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.55 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CYP4B1 | P13584 | 1/20 | 0.55 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.55 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.55 |
| ▸ | CYP2A7 | P20853 | 1/20 | 0.55 |
| ▸ | CYP3A7 | P24462 | 1/20 | 0.55 |
| ▸ | CYP2F1 | P24903 | 1/20 | 0.55 |
| ▸ | CYP2C18 | P33260 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.55 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.55 |
| ▸ | CYP4F8 | P98187 | 1/20 | 0.55 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1650160 | 0.98 | MAOB (0.54) | CYP3A4CYP1A1CYP1A2CYP2E1CYP2C8 | |
| SCHEMBL29868542 | 0.88 | DHODH (0.51) | CYP3A4CYP1A1CYP1A2CYP2E1CYP2C8 | |
| SCHEMBL1337887 | 0.84 | MAOB (0.55) | CYP3A4CYP1A1CYP1A2CYP2E1CYP2C8 | |
| SCHEMBL12777827 | 0.82 | CYP1A1 (0.55) | CYP3A4CYP1A1CYP1A2CYP2E1CYP2C8 | |
| SCHEMBL1650912 | 0.82 | ENPP2 (0.55) | CYP3A4CYP1A1CYP1A2CYP2E1CYP2C8 | |
| SCHEMBL1336946 | 0.81 | RXRA (0.51) | CYP1A2CYP2C19MAP4K4DHODHBACE1 | |
| SCHEMBL1337634 | 0.81 | TP53 (0.54) | CYP3A4KDM4EMAP4K4DHODH | |
| SCHEMBL3731784 | 0.81 | KDM1A (0.53) | CYP3A4CYP1A1CYP1A2CYP2E1CYP2C8 | |
| SCHEMBL196765 | 0.80 | CYP3A4 (0.73) | CYP3A4CYP1A1CYP1A2CYP2E1CYP2C8 | |
| SCHEMBL29489425 | 0.80 | CYP3A4 (0.73) | CYP3A4CYP1A1CYP1A2CYP2E1CYP2C8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2488497-B1 | PROCESS FOR MANUFACTURING 2-[(3,5-DIFLUORO-3'-METHOXY-1,1'-BIPHENYL-4-YL)AMINO]NICOTINIC ACID | ALMIRALL SA (ES) | 2014-03-12 | — | — | EP | claimed |
| US-8598363-B2 | Process for manufacturing 2-[(3,5-difluoro-3′-methoxy-1,1′biphenyl-4-yl)amino]nicotinic acid | ALMIRALL, S.A. (ES) | 2013-12-03 | — | — | US | claimed |
| US-20120245359-A1 | PROCESS FOR MANUFACTURING 2-[(3,5-DIFLUORO-3'-METHOXY-1,1'-BIPHENYL-4 YL)AMINO]NICOTINIC ACID | ALMIRALL, S.A. (ES) | 2012-09-27 | — | — | US | claimed |
| EP-2488497-A1 | PROCESS FOR MANUFACTURING 2-[(3,5-DIFLUORO-3'-METHOXY-1,1'-BIPHENYL-4-YL)AMINO]NICOTINIC ACID | Almirall S.A. (ES) | 2012-08-22 | — | — | EP | claimed |
| EP-2314577-A1 | Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid | Almirall, S.A. (ES) | 2011-04-27 | — | — | EP | claimed |
| WO-2011045059-A1 | PROCESS FOR MANUFACTURING 2-[(3,5-DIFLUORO-3'-METHOXY-1,1'-BIPHENYL-4-YL)AMINO]NICOTINIC ACID | ALMIRALL, S.A. (ES) | 2011-04-21 | — | — | WO | claimed |
| US-20260130879-A1 | VIDOFLUDIMUS AND RELATED STRUCTURES ACTING AS NURR1 AGONISTS | IMMUNIC AG (DE) | 2026-05-14 | — | — | US | disclosed |
| US-20240335405-A1 | VIDOFLUDIMUS AND RELATED STRUCTURES ACTING AS NURR1 AGONISTS | IMMUNIC AG (DE) | 2024-10-10 | — | — | US | disclosed |
| WO-2023118576-A1 | DHODH INHIBITORS CONTAINING A CARBOXYLIC ACID BIOISOSTERE | IMMUNIC AG (DE) | 2023-06-29 | — | — | WO | disclosed |
| US-9758474-B2 | Immunomodulator and anti-inflammatory compounds | INCOZEN THERAPEUTICS PVT. LTD. (IN) | 2017-09-12 | — | — | US | disclosed |
| CN-102574800-B | Method for producing 2- [ (3, 5-difluoro-3 '-methoxy-1, 1' -biphenyl-4-yl) amino ] nicotinic acid | ALMIRALL SA | 2014-09-17 | — | — | CN | disclosed |
| US-20140220050-A1 | NOVEL IMMUNOMODULATOR AND ANTI-INFLAMMATORY COMPOUNDS | INCOZEN THERAPEUTICS PVT. LTD. (CH) | 2014-08-07 | — | — | US | disclosed |
| CN-103936668-A | Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid | ALMIRALL SA | 2014-07-23 | — | — | CN | disclosed |
| EP-2314577-A1 | Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid | Almirall, S.A. (ES) | 2011-04-27 | — | — | EP | disclosed |
| WO-2011045059-A1 | PROCESS FOR MANUFACTURING 2-[(3,5-DIFLUORO-3'-METHOXY-1,1'-BIPHENYL-4-YL)AMINO]NICOTINIC ACID | ALMIRALL, S.A. (ES) | 2011-04-21 | — | — | WO | disclosed |
| WO-2011045059-A1 | PROCESS FOR MANUFACTURING 2-[(3,5-DIFLUORO-3'-METHOXY-1,1'-BIPHENYL-4-YL)AMINO]NICOTINIC ACID | ALMIRALL, S.A. (ES) | 2011-04-21 | — | — | WO | disclosed |
| WO-2011045059-A1 | PROCESS FOR MANUFACTURING 2-[(3,5-DIFLUORO-3'-METHOXY-1,1'-BIPHENYL-4-YL)AMINO]NICOTINIC ACID | ALMIRALL, S.A. (ES) | 2011-04-21 | — | — | WO | disclosed |
| US-20100074898-A1 | AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS | LABORATORIOS ALMIRALL, S.A. (ES) | 2010-03-25 | — | — | US | disclosed |
| EP-2121614-A1 | AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS | Almirall, S.A. (ES) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008077639-A1 | AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS | LABORATORIOS ALMIRALL, S.A. (ES) | 2008-07-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140220050-A1 | NOVEL IMMUNOMODULATOR AND ANTI-INFLAMMATORY COMPOUNDS | DHODH, DLD, DHFR | CYP3A4 1738/4885CYP1A1 1640/4885CYP1A2 1449/4885 |
| US-20260130879-A1 | VIDOFLUDIMUS AND RELATED STRUCTURES ACTING AS NURR1 AGONISTS | NR0B1, NR4A1, NR4A2 | CYP3A4 1859/4885CYP1A1 1272/4885CYP1A2 1784/4885 |
| US-20100074898-A1 | AMINO NICOTINIC AND ISONICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS | DHODH, NQO2, DAO | CYP3A4 2249/4885CYP1A1 1233/4885CYP1A2 1156/4885 |
| US-20120245359-A1 | PROCESS FOR MANUFACTURING 2-[(3,5-DIFLUORO-3'-METHOXY-1,1'-BIPHENYL-4 YL)AMINO]NICOTINIC ACID | GART, NAPRT, NNMT | CYP3A4 270/4885CYP1A1 127/4885CYP1A2 494/4885 |
| US-20240335405-A1 | VIDOFLUDIMUS AND RELATED STRUCTURES ACTING AS NURR1 AGONISTS | NR4A1, NR4A2, NR0B1 | CYP3A4 2354/4885CYP1A1 1772/4885CYP1A2 2388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.